Tandem Diabetes Care, Inc. (LON:0M0F)

Market Cap	847.50M -19.3%
Revenue (ttm)	778.16M +4.5%
Net Income	-71.60M
EPS	-1.06
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,152
Open	15.90
Previous Close	16.59
Day's Range	15.39 - 16.21
52-Week Range	10.03 - 29.47
Beta	1.64
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 5, 2026

About Tandem Diabetes Care

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It’s flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user’s body. In addition, it offers Tandem Device Updater used to update the pump software from a pe...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2006
• Employees: 2,500
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0M0F

Financial Performance

In 2025, Tandem Diabetes Care's revenue was $1.01 billion, an increase of 7.93% compared to the previous year's $940.20 million. Losses were -$204.71 million, 113.2% more than in 2024.

Financial numbers in USD